NCT06482905 2026-01-06Safety and Efficacy Study of TX103 CAR-T Cell Therapy for Recurrent or Progressive Grade 4 Glioma.Tcelltech Inc.Phase 1 Recruiting52 enrolled
NCT04808245 2025-09-22INTERCEPT-H3German Cancer Research CenterPhase 1 Active not recruiting15 enrolled